Both fasting and GLP-1s contribute to weight loss by creating a negative energy balance, but the ways they converge on autophagy present a compelling narrative for metabolic health. Fasting induces autophagy as a direct response to nutrient scarcity, tapping into an ancient survival mechanism.
This narrative review focuses on fasting and postprandial GLP-1 secretion in individuals with different metabolic conditions and degrees of glucose intolerance.
Obesity remains a major global health challenge, with glucagon-like peptide-1 receptor agonists (GLP-1RAs) providing substantial yet sensitive benefits in weight reduction, glycemic control, and cardiovascular protection. Despite robust trial data, real-world persistence is limited by cost, tolerability, and hedonic adaptation. Intermittent fasting and time-restricted eating offer ...
Layering intermittent fasting on top can push your body into excessive calorie restriction, nutrient deficiencies, blood sugar crashes, and severe malnutrition. Fasting while on a GLP-1 can also worsen nausea, fatigue, and GI symptoms.
Combining fasting with GLP-1 weight loss treatments can be a powerful strategy to accelerate weight loss, improve metabolic health, and achieve your goals. By choosing the right fasting method, prioritizing nutrition, and following expert guidance, you can safely optimize your results.
Glucagon is a well-known polypeptide that induces autophagy. In contrast, GLP-1 has been shown to inhibit glucagon secretion; GLP-1 also has been related to the induction of autophagy. DPP-4 inhibitors can induce autophagy in a GLP-1dependent manner, but other diverse effects could be relevant.
